Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Disease area: Airway diseases, Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Ali (Telford, United Kingdom), J. Ibrahim (Telford, United Kingdom), J. Ali (Telford, United Kingdom), M. Radzali (Telford, United Kingdom), J. Ahmed (Telford, United Kingdom), H. Moudgil (Telford, United Kingdom), E. Crawford (Telford, United Kingdom), A. Makan (Telford, United Kingdom), K. Srinivasan (Telford, United Kingdom), N. Ahmad (Telford, United Kingdom). Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) - is it a separate entity?. 4096

Member's Comments

No comment yet.

Related content which might interest you: Chronic Obstructive Pulmonary Disease (COPD) Source: Eur Respir Rev 2009; 18: 133 Year: 2009 Sexuality in Chronic Obstructive Pulmonary Disease (SEXY COPD) Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases Year: 2020 “Asthma-like features” in Chronic Obstructive Pulmonary Disease (COPD) patients Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Putative role of Eosinophilic cells in Chronic Obstructive Pulmonary Disease (COPD) Source: International Congress 2017 – Translational studies of lung disease Year: 2017 Chronic Obstructive Pulmonary Disease Exacerbations Source: Eur Respir Rev 2009; 18: 305 Year: 2009 Metabolic Syndrome (MetS) as a comorbidity of Chronic Obstructive Pulmonary Disease (COPD) Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases Year: 2021 Pharmacological treatment of stable Chronic Obstructive Pulmonary Disease: Where do we stand? Source: International Congress 2018 – COPD management Year: 2018 Dysfunctional breathing impacts symptom burden in Chronic Obstructive Pulmonary Disease (COPD). Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Metabolic paralysis in systemic immune cells of Chronic Obstructive Pulmonary Disease (COPD) subjects. Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 Association of Metabolic Syndrome with the severity of Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Pathogenic bacteria for exacerbation of Chronic Obstructive Pulmonary Disease Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 The Aetiology of Acute Exacerbations in Chronic Obstructive Pulmonary Disease (AECOPD): A Systematic Literature Review (SLR) Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Cardiac Involvement In Chronic Obstructive Pulmonary Disease (COPD) Secondary To Post TB Bronchiectasis V/S Non Post Tb Bronchiectasis Source: International Congress 2019 – Bronchiectasis Year: 2019 Level of control of Chronic Obstructive Pulmonary Disease according to clinical phenotypes. Study SINCON Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017 The Impact of Multimorbidity on Hospitalizations in Patients with Chronic Obstructive Pulmonary Disease (COPD): a Population-Based Study Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision Source: Eur Respir J, 56 (1) 2000627; 10.1183/13993003.00627-2020 Year: 2020 Effectiveness of pulmonary rehabilitation initiated after exacerbation of Chronic Obstructive Pulmonary Disease Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care Year: 2018 Upper Respiratory Symptoms in Patients with Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020 Role of eosinopenia in predicting mortality and morbidity in patients with Chronic Obstructive Pulmonary Disease (COPD) Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Assessment of lung function in symptomatic and asymptomatic smokers without Chronic Obstructive Pulmonary Disease (COPD) using the Impulse Oscillatory Technique (IOT) Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco Year: 2020